Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals w...
Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and European League Against Rheumatism
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and European League Against Rheumatism
Subjects
More information
Scope and Contents
Contents
Recently, it has become clear that ACPA can display cross-reactivity to other post-translational modifications (PTMs), more specifically homocitrulline and acetyllysine, as shown at both the monoclonal and polyclonal antibody level.2 3 B cell receptor analysis of ACPA-expressing B cells from patients with RA has shown that ACPAs have undergone exte...
Alternative Titles
Full title
Cross-reactivity of anti-modified protein antibodies is also present in predisease and individuals without rheumatoid arthritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_umu_196182
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_umu_196182
Other Identifiers
ISSN
0003-4967,1468-2060
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2022-222326
